Singapore #9108 (v.1)
Base data
- Notified in
-
G/MA/QR/N/SGP/6 06/11/2024
- Version validity
-
11/04/2023 -
01/09/2024
Old version v.1
- Reporting member
- Singapore
- In force from
- End date
- In force
- General description
-
Non-automatic licence for the import of Cell, Tissue, and Gene Therapy Products
- National legal basis
-
Health Products Act, 2007
Health Products (Cell, Tissue, and Gene Therapy Products) Regulations, 2021 - Administrative mechanism
-
The regulation of cell, tissue and gene therapy products is under the Health Products (Cell, Tissue and Gene Therapy_ Regulations 2021.
More information can be found at: https://www.hsa.gov.sg/ctgtp/dealers-licence.
Administered by HSA. - Responsible entities
-
Health Sciences Authority
- HS version
-
HS 2022
- Referenced WTO document symbol
Meta data
- WTO justifications
-
XX:(b) - (b) necessary to protect human, animal or plant life or health;
GATT 1994 (GATT 1947 provisions)
Reported as: Article XX(b) of the GATT - Non-WTO commitments
-
- Affected partners
- Non-affected partners
Measures
- Reported restrictions
- NAL
| Symbol |
|---|
|
NAL
|
Tariff lines
|
30
|
Chapter 30
|
Cell, tissue, and gene therapy products refer to cellular-, tissue- or gene-based therapeutic produc...
|
|